Related Experiment Video
Updated: May 5, 2026

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
DLEC1 Expression Is Modulated by Epigenetic Modifications in Hepatocelluar Carcinoma Cells: Role of HBx Genotypes
Dandan Niu1, Huixing Feng, Wei Ning Chen
1School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore. wnchen@ntu.edu.sg.
Abstract:
Deleted in Lung and Esophageal Cancer 1 (DLEC1) is a functional tumor suppressor gene (TSG). It has been found to be silenced in a variety of human cancers including hepatocellular carcinoma (HCC). The silencing of DLEC1 can be modulated by epigenetic modifications, such as DNA hypermethylation and histone hypoacetylation. In the case of HCC, hepatitis B virus X protein (HBx) has been implicated in methylation of target promoters resulting in the down-regulation of tumor suppressor genes, which in turn contributes to the development of HCC. In the present study, we first established a cell system in which epigenetic modifications can be modulated using inhibitors of either DNA methylation or histone deacetylation. The cell system was used to reveal that the expression of DLEC1 was upregulated by HBx in a genotype-dependent manner. In particular, HBx genotype A was found to decrease DNA methylation of the DLEC1 promoter. Our results have provided new insights on the impact of HBx in HCC development by epigenetic modifications.
Insights
Hepatitis B virus X protein (HBx) influences Deleted in Lung and Esophageal Cancer 1 (DLEC1) gene expression in liver cancer. HBx genotype A specifically reduces DLEC1 promoter methylation, impacting tumor suppressor activity.
Area of Science:
- Oncology
- Hepatology
- Epigenetics
Background:
- Deleted in Lung and Esophageal Cancer 1 (DLEC1) is a tumor suppressor gene frequently silenced in human cancers, including hepatocellular carcinoma (HCC).
- Epigenetic modifications like DNA hypermethylation and histone hypoacetylation are key mechanisms for DLEC1 gene silencing.
- The hepatitis B virus X protein (HBx) is implicated in promoting HCC by down-regulating tumor suppressor genes via promoter methylation.
Purpose of the Study:
- To investigate the impact of HBx on DLEC1 expression and its epigenetic regulation in HCC.
- To elucidate the role of different HBx genotypes in modulating DLEC1 promoter methylation.
Main Methods:
- Establishment of a cellular system allowing modulation of DNA methylation and histone deacetylation.
- Treatment with inhibitors of DNA methylation or histone deacetylation to study epigenetic modifications.
- Analysis of DLEC1 expression levels in response to HBx and epigenetic modulators.
Main Results:
- DLEC1 expression was found to be upregulated by HBx in a genotype-dependent manner.
- Specifically, HBx genotype A was observed to decrease DNA methylation at the DLEC1 promoter.
- These findings highlight a direct link between HBx genotype and epigenetic regulation of DLEC1.
Conclusions:
- HBx plays a significant role in the epigenetic modulation of DLEC1 in HCC.
- HBx genotype A contributes to HCC development by reducing DLEC1 promoter methylation.
- This study provides novel insights into the mechanisms underlying HBx-associated HCC pathogenesis through epigenetic alterations.
Related Concept Videos
Cell Specific Gene Expression
Inheritance of Chromatin Structures
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Histone Modification

